Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04123093 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the Noxsano Wound Care Bandage
A NA study, sponsored by OhioHealth.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT04123093: Clinical Trial NA study, sponsored by OhioHealth.
NCT04123093 is a NA study that was terminated before completion, run by OhioHealth. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04123093, a NA study, was terminated before completion, sponsored by OhioHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study is a prospective, interventional, non-randomized study designed to assess the safety and efficacy of the Noxsano Bandage (study device) in healthy subjects and wound care subjects with a diabetic lower extremity ulceration and/or arterial insufficiency lower extremity ulceration.
Primary Outcome
Adverse events related to the Noxsano bandage will be assessed using a safety and adverse reactions questionnaire that includes questions for the subject regarding tolerance, side effects, and adverse events.
Interventions
- DEVICE Noxsano Bandage (Healthy Volunteers)
- DEVICE Noxsano Bandage (Wound Care)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-08-09 |
| Est. Completion | 2020-09-09 |
| Phase | NA |
Why NCT04123093 stopped before completion
NCT04123093 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Noxsano Bandage (Healthy Volunteers) is the first listed.
NCT04123093 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04123093 about?
NCT04123093 is a clinical study titled "Safety and Efficacy of the Noxsano Wound Care Bandage". This study is a prospective, interventional, non-randomized study designed to assess the safety and efficacy of the Noxsano Bandage (study device) in healthy subjects and wound care subjects with a diabetic lower extremity ulceration and/or arterial insufficiency lower extremity ulceration.
What is the current status of trial NCT04123093?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2019-08-09. Estimated completion is 2020-09-09.
What interventions are being tested in trial NCT04123093?
The interventions under investigation include: Noxsano Bandage (Healthy Volunteers) (DEVICE), Noxsano Bandage (Wound Care) (DEVICE).
Who is sponsoring clinical trial NCT04123093?
This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04123093's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI